title: Nanoparticles for immune system targeting.
abstract: Nanoparticles (NPs) are found in numerous applications used to modulate the immune system. They serve as drug delivery carriers or vaccine adjuvants and are utilized as therapeutics against a variety of diseases. NPs can be engineered to target distinct cellular components representing multiple pathways of immunity. The combination of NPs with immune system-targeting moieties has paved the way for improved targeted immune therapies. Here we provide an update of recent progress in this field.
authors.affiliation: Centre for Translational Microbiome Research (CTMR), Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177 Stockholm, Sweden. Electronic address: Juan.Du@ki.se.
authors.forename: Juan
authors.initials: J
authors.lastname: Du
authors.affiliation: Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
authors.forename: Yu Shrike
authors.initials: YS
authors.lastname: Zhang
authors.affiliation: School of Life Science and Technology, Xi'an Jiaotong University, Shaanxi 710049, China.
authors.forename: Divia
authors.initials: D
authors.lastname: Hobson
authors.affiliation: Department of Oncology-Pathology, Karolinska Institutet, 17176 Stockholm, Sweden. Electronic address: Per.Hydbring@ki.se.
authors.forename: Per
authors.initials: P
authors.lastname: Hydbring
mesh_terms: D056704:Adaptive Immunity / Q000187:drug effects*; D000818:Animals; D016503:Drug Delivery Systems; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects*; D053758:Nanoparticles / Q000627:therapeutic use*